TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/30/2025
Back to search
Official data from USPTO
INTRALIPID
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INTRALIPID
ST13
US500000072168762Class
5, 18
Filing
72168762
Registration
762641
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
10/08/2025
Trademark type
Word
Nice classes
5, 18
Filing date
05/13/1963
Registration date
01/07/1964
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/18/2024
Last transaction
10/08/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/08/1961
First use in commerce
12/08/1961
Drawing code
1
Owner type
03
Owner location
UPPSALA, SE
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
FRESENIUS KABI AB
V. A. (pessoa física)
Riker Laboratories, Inc.
Representatives
Paul Cosmovici
Technical classification
Nice Classes
Class 5Class 18
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
No specification.
Class 18
Fat Emulsion for Intravenous Injection
Publications
History of USPTO decisions and trademark events.
20 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/30/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/30/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/18/2024
RNL3
REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
04/18/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/18/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/18/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
12/13/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/07/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/18/2013
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
11/18/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/18/2013
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
11/14/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
11/14/2013
CFIT
CASE FILE IN TICRS
10/29/2008
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/09/2004
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/09/2004
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
12/05/2003
E89R
TEAS SECTION 8 & 9 RECEIVED
12/05/2003
REN1
REGISTERED AND RENEWED (FIRST RENEWAL - 20 YRS)
01/07/1984
Continuous trademark protection
Get notified about every new filing that threatens INTRALIPID or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.